Author:
Hubeek I,Stam R W,Peters G J,Broekhuizen R,Meijerink J P P,Wering E R van,Gibson B E S,Creutzig U,Zwaan C M,Cloos J,Kuik D J,Pieters R,Kaspers G J L
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Amici A, Emanuelli M, Magni G, Raffaelli N, Ruggieri S (1997) Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides. FEBS Lett 419: 263–267
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103: 620–625
3. Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res 58: 4173–4179
4. Bolwell BJ, Cassileth PA, Gale RP (1988) High dose cytarabine: a review. Leukemia 2: 253–260
5. Capizzi RL, Yang JL, Rathmell JP, White JC, Cheng E, Cheng YC, Kute T (1985) Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation. Semin Oncol 12: 65–74
Cited by
125 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献